Christopher Verni's most recent trade in Vigil Neuroscience Inc was a trade of 150,000 Stock Option Award (Right to Buy) done . Disclosure was reported to the exchange on May 3, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vigil Neuroscience Inc | Christopher Verni | General Counsel | 03 May 2024 | 150,000 | 0 | - | - | Stock Option Award (Right to Buy) | ||
| Vigil Neuroscience Inc | Christopher Verni | General Counsel | 03 May 2024 | 150,000 | 150,000 | - | - | Stock Option Award (Right to Buy) | ||
| Vigil Neuroscience Inc | Christopher Verni | General Counsel | 03 May 2024 | 85,000 | 0 | - | - | Stock Option Award (Right to Buy) | ||
| Vigil Neuroscience Inc | Christopher Verni | General Counsel | 03 May 2024 | 85,000 | 85,000 | - | - | Stock Option Award (Right to Buy) | ||
| Vigil Neuroscience Inc | Christopher Verni | General Counsel | 01 Mar 2024 | 116,000 | 116,000 | - | - | Stock Option Grant (Right to Buy) | ||
| Vigil Neuroscience Inc | Christopher Verni | General Counsel | 01 Mar 2023 | 85,000 | 85,000 | - | - | Stock Option Grant (Right to Buy) | ||
| Vigil Neuroscience Inc | Christopher Verni | General Counsel | 03 May 2022 | 4,000 | 4,000 | - | 3.8 | 15,074 | Common Stock | |
| Vigil Neuroscience Inc | Christopher Verni | General Counsel | 19 Apr 2022 | 150,000 | 150,000 | - | - | Stock Option Grant (Right to Buy) |